John B. Robbins
John Bennett Robbins (born December 1, 1932)[1] is a senior investigator at the National Institutes of Health, best known for his development of the vaccine against bacterial meningitis (Haemophilus influenzae type B (Hib)) with his colleague Rachel Schneerson.
Bacterial meningitis is the leading cause of acquired mental retardation in children.
Robbins is a recipient of the 1996 Albert Lasker Award for Clinical Medical Research,[2] the Pasteur Award from the World Health Organization and the Albert B. Sabin Gold Medal in 2001 which he received for playing a major role in the development of Hib conjugate vaccine that is now used throughout the world and has led to a dramatic decline in the number of infants and children suffering from meningitis and other systemic infections such as osteomyelitis and pneumonia.[3] In 2017 he, and his colleagues, also received the Prince Mahidol Award (Public Health) in Thailand for this work.[4] He is a member of the National Academy of Science.
References
- ^ Who's who in Government, Volume 3
- ^ "The Lasker Foundation". Archived from the original on 16 January 2014. Retrieved 16 January 2014.
{{cite web}}: Unknown parameter|deadurl=ignored (|url-status=suggested) (help) - ^ "The Albert B. Sabin Gold Medal Award". The Sabin Vaccine Institute. Retrieved 16 January 2014.
- ^ "Biography of laureate". Prince Mahidol Award Foundation.
- http://www.nichd.nih.gov/about/staff/bio.cfm?nih_id=0010046803
- http://www.polio.pitt.edu/speakers/robbins.htm
| International | |
|---|---|
| National | |
   | This biographical article related to medicine in the United States is a stub. You can help Wikipedia by expanding it. |